Victoza
Payments companies reported to CMS as associated with Victoza. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Victoza, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Victoza
These are the largest totals companies reported as associated with Victoza. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Adam De Havenon | New Haven, CT | Vascular Neurology | $38,625.00 |
| Neda Rasouli | Aurora, CO | Endocrinology, Diabetes & Metabolism | $28,218.62 |
| Carolina Solis-Herrera | San Antonio, TX | Endocrinology, Diabetes & Metabolism | $24,523.81 |
| Vanita Aroda | Boston, MA | Endocrinology, Diabetes & Metabolism | $16,953.49 |
| Richard Pratley | Orlando, FL | Endocrinology, Diabetes & Metabolism | $15,951.76 |
| Maria Caramori | Minneapolis, MN | Endocrinology, Diabetes & Metabolism | $14,440.31 |
| John Buse | Chapel Hill, NC | Endocrinology, Diabetes & Metabolism | $13,669.49 |
| Aaron King | San Antonio, TX | Family Medicine | $12,994.82 |
| Ralph Defronzo | San Antonio, TX | Endocrinology, Diabetes & Metabolism | $12,915.85 |
| Carlos Campos | New Braunfels, TX | Family Medicine | $12,472.22 |
Prescribed Victoza?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.